This result is consistent with the findings in myelodysplastic syndromes (MDS) (26), in which S100A9 lead abnormal increase of myeloid-derived suppressor cells and suppressive cytokines IL-10 and TGF-β and finally contributed to immunosuppression, inflammation, and cancer. The gene discussed is S100A9; the disease is cancer.